New York State Common Retirement Fund lowered its position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 3.6% during the fourth quarter, Holdings Channel.com reports.

IRVINE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced financial results for the fourth quarter and full-year ended December 31, 2024 ...

"Tarsus' demonstrated category-creating blueprint has established XDEMVY as one of the most successful eye care launches to date,” said Bobak Azamian, M.D., Ph.D., Chief Executive Officer and Chairman ...

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a ...

Saul Bal, 41, is accused of shooting Phoenix PD Officers Zane Coolidge and Matthew Haney. Officer Coolidge died days after the shooting. Officer Haney survived. Bal is being held on a $2 million ...

David Lunn and Teresa Ruiz claimed the men’s and women’s titles in the David Saul Memorial 5K Run today [March 2]. Lunn finished in a time in 17min 25sec, with Philip Woollins second in 17:41 ...

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a ...

UN experts have accused Israel of committing sexual violence in Gaza, targeting hospitals and civilians, disproportionately affecting women and children. Israel rejects the UN's findings, labeling ...